The newly reported studies demonstrated that the antibodies, in a T cell engager format, can effectively kill cancer cells expressing relevant HER2 mutations both in vitro, and in a mouse ...
In the early 20th century, researchers mainly used mice to study cancer. They found that they could only transmit cancer to mice that had a specific mutation but not to animals lacking the mutation.